The effect of evolving trauma care on the development of multiple organ dysfunction syndrome

European Journal of Trauma and Emergency Surgery

Volumn 40, Issue 2, 2014, Pages 127-134

  van Wessem, K J P ^a   Leenen, L P H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Inflammatory response; Organ failure; Polytrauma

Indexed keywords

EID: 84898547428     PISSN: 18639933     EISSN: 16153146     Source Type: Journal    
DOI: 10.1007/s00068-014-0392-9     Document Type: Review

References (66)

1. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock. 1998;10: 79-89.
2. Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure. Arch Surg. 2005;140: 432-40.
3. Dewar DC, Tarrant SM, King KL, Balogh ZJ. Changes in the epidemiology and prediction of multiple-organ failure after injury. J Trauma Acute Care Surg. 2013;74(3): 774-9.
4. Goris RJ, Gimbrère JS, van Niekerk JL, Schoots FJ, Booy LH. Early osteosynthesis and prophylactic mechanical ventilation in the multitrauma patient. J Trauma. 1982;22(11): 895-903.
5. Bone LB, Johnson KD, Weigelt J, Scheinberg R. Early versus delayed stabilization of femoral fractures. A prospective randomized study. J Bone Joint Surg Am. 1989;71(3): 336-40.
6. Rotondo MF, Schwab CW, McGonigal MD, Phillips GR 3rd, Fruchterman TM, Kauder DR, Latenser BA, Angood PA. "Damage control": an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35: 375-82 (discussion 382-383).
7. Burch JM, Ortiz VB, Richardson RJ, Martin RR, Mattox KL, Jordan GL. Abbreviated laparotomy and planned reoperation for critically injured patients. Ann Surg. 1992;215: 476-84.
8. Morris JA, Eddy VA, Blirman TA, Rutherford EJ, Sharp EW. The staged coeliotomy for trauma: issues in unpacking and reconstruction. Ann Surg. 1993;217: 576-86.
9. Shapiro MB, Jenkins DH, Schwab CW, Rotondo MF. Damage control: collective review. J Trauma. 2000;49: 969-78.
10. Pape HC, Auf'm'Kolk M, Paffrath T, Regel G, Sturm JA, Tscherne H. Primary intramedullary femur fixation in multiple trauma patients with associated lung contusion-a cause of posttraumatic ARDS? J Trauma. 1993;34(4): 540-7 (discussion 547-548).
11. Pape HC, Krettek C. Management of fractures in the severely injured-influence of the principle of "damage control orthopaedic surgery". Unfallchirurg. 2003;106(2): 87-96.
12. Pape HC, Hildebrand F, Pertschy S, Zelle B, Garapati R, Grimme K, Krettek C, Reed RL 2nd. Changes in the management of femoral shaft fractures in polytrauma patients: from early total care to damage control orthopedic surgery. J Trauma. 2002;53(3): 452-61 (discussion 461-462).
13. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrère JS. Multiple organ failure: generalized autodestructive inflammation. Arch Surg. 1985;120(10): 1109-15.
14. Rotstein OD. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma. 2003;54(Suppl. 5): 203-6.
15. Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36: 691-709.
16. Botha AJ, Moore FA, Moore EE, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery. 1995;118: 358-65.
17. Zallen G, Moore EE, Johnson JL, Tamura JY, Aiboshi J, Biffl WL, Silliman CC. Circulating postinjury neutrophils are primed for the release of pro-inflammatory cytokines. J Trauma. 1999;46: 42-8.
18. Koenderman L, Kanters D, Maesen B, Raaijmakers J, Lammers JW, de Kruijf J, Logtenberg T. Monitoring of neutrophil priming in whole blood by antibodies isolated from a synthetic phage antibody library. J Leukoc Biol. 2000;68: 58-64.
19. Raoof M, Zhang Q, Itagaki K, Hauser CJ. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J Trauma. 2010;68: 1328-32 (discussion 1332-1334).
20. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006;368: 157-69.
21. Lee KM, Seong SY. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern. Immunol Lett. 2009;125: 31-9.
22. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464: 104-7.
23. Seekamp A, Jochum M, Ziegler M, van Griensven M, Martin M, Regel G. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma. 1998;44: 874-82.
24. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24: 1125-8.
25. Moore FA, Moore EE, Kim FJ, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery. 1995;118: 358-65.
26. Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009;101: 36-47.
27. Cavaillon JM, Adib-Conquy M, Cloëz-Tayarani I, Fiiting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endoxin Res. 2011;7: 85-93.
28. Hietbrink F, Oudijk EJ, Braams R, Koenderman L, Leenen L. Aberrant regulation of polymorphonuclear phagocyte responsiveness in multitrauma patients. Shock. 2006;26(6): 558-64.
29. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg. 2006;141(11): 1132-40.
30. Waydhas C, Nast Kolb D, Kick M. Operations-planung von sekundären eingriffen nach polytrauma. Unfallchirurg. 1994;97: 244.
31. Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury. 2007;38: 1358-64.
32. Adams JM, Hauser CJ, Livingston DH, Fekete Z, Hasko G, Forsythe RM, Deitch EA. The immunomodulatory effects of damage control abdominal packing on local and systemic neutrophil activity. J Trauma. 2001;50: 792-800.
33. Pape HC, Grimme K, van Griensven M, Sott AH, Giannoudis P, Morley J, Roise O, Ellingsen E, Hildebrand F, Wiese B, Krettek C, EPOFF Study Group. Impact of intramedullary instrumentation versus damage control for femoral fractures on immuno-inflammatory parameters; prospective randomized analysis by the EPOFF study group. J Trauma. 2003;55: 7-13.
34. Pape HC, Giannoudis P, Krettek C. The timing of fracture treatment in polytrauma patients: relevance of damage control orthopedic surgery. Am J Surg. 2002;183: 622-9.
35. Pape HC, Rixen D, Morley J, Ellingsen Husebye E, Mueller M, Dumont C, Gruner A, Oestern HJ, Bayeff-Filoff M, Garving C, Pardini D, van Griensven M, Krettek C, Giannoudis P, EPOFF study group. Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients). Ann Surg. 2007;246: 491-501.
36. Lichte P, Kobbe P, Dombroski D, Pape HC. Damage control orthopedics: current evidence. Curr Opin Crit Care. 2012;18(6): 647-50.
37. Nicholas B, Toth L, van Wessem K, Evans J, Enninghorst N, Balogh ZJ. Borderline femur fracture patients: early total care or damage control orthopaedics? ANZ J Surg. 2011;81(3): 148-53.
38. O'Toole RV, O'Brien M, Scalea TM, Habashi N, Polak AN, Turen CH. Resuscitation before stabilization of femoral fractures limits acute respiratory distress syndrome in patients with multiple traumatic injuries despite low use of damage control orthopedics. J Trauma. 2009;67: 1013-21.
39. Cirocchi R, Abraha I, Montedori A, Farinella E, Bonacini I, Tagliabue L, Sciannameo F. Damage control surgery for abdominal trauma. Cochrane Database Syst Rev. 2010;1: CD007438. doi: 10. 1002/14651858. CD007438. pub2.
40. Cirocchi R, Montedori A, Farinella E, Bonacini I, Tagliabue L, Abraha I. Damage control surgery for abdominal trauma. Cochrane Database Syst Rev. 2013;3: CD007438. doi: 10. 1002/14651858. CD007438. pub3.
41. Pape H, Stalp M, van Griensven M, Weinberg A, Dahlweit M, Tscherne H. Optimal timing for secondary surgery in polytrauma patients: an evaluation of 4, 314 serious-injury cases. Chirurg. 1999;70: 1287-93.
42. Pape HC. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers. J Trauma. 2001;50: 989-1000.
43. Flohé S, Lendemans S, Schade FU, Kreuzfelder E, Waydhas C. Influence of surgical intervention in the immune response of severely injured patients. Intensive Care Med. 2004;30: 96-102.
44. Miller RS, Morris JA Jr, Diaz JJ Jr, Herring MB, May AK. Complications after 344 damage control open celiotomies. J Trauma. 2005;59: 1365-71.
45. Bradley MJ, Dubose JJ, Scalea TM, Holcomb JB, Shrestha B, Okoye O, Inaba K, Bee TK, Fabian TC, Whelan JF, Ivatury RR, AAST Open Abdomen Study Group. Independent predictors of enteric fistula and abdominal sepsis after damage control laparotomy: results from the prospective AAST Open Abdomen registry. JAMA Surg. 2013;148(10): 947-54.
46. DuBose JJ, Scalea TM, Holcomb JB, AAST Open Abdomen Study Group, et al. Open abdominal management after damage-control laparotomy for trauma: a prospective observational American Association for the Surgery of Trauma multicenter study. J Trauma Acute Care Surg. 2013;74(1): 113-20.
47. Diaz JJ, Cullinane DC, Dutton WD, Jerome R, Bagdonas R, Bilaniuk JO. The management of the open abdomen in trauma and emergency general surgery: part 1-damage control. J Trauma. 2010;68: 1425-38.
48. Demetriades D, Salim A. The management of the open abdomen. Surg Clin N Am. 2014;94: 131-53.
49. van Boele Hensbroek P, Wind J, Dijkgraaf MGW, Busch ORC, Goslings JC. Temporary closure of the open abdomen. World J Surg. 2009;33: 199-207.
50. Abikhaled JA, Granchi TS, Wall MJ, Hirshberg A, Mattox KL. Prolonged abdominal packing for trauma is associated with increased morbidity and mortality. Am Surg. 1997;63(12): 1109-12 (discussion 1112-1113).
51. Burlew CC, Moore EE, Biffl WL, Bensard DD, Johnson JL, Barnett CC. One hundred percent fascial approximation can be achieved in the postinjury open abdomen with a sequential closure protocol. J Trauma Acute Care Surg. 2012;72(1): 235-41.
52. Sauaia A, Moore FA, Moore EE, Norris JM, Lezotte DC, Hamman RF. Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma. 1998;45: 291-301 (discussion 303).
53. Groeneveld KM, Leenen LP, Koenderman L, Kesecioglu J. Immunotherapy after trauma: timing is essential. Curr Opin Anaesthesiol. 2011;24(2): 219-23.
54. Hietbrink F, Koenderman L, Althuizen M, Pillay J, Kamp V, Leenen LP. Kinetics of the innate immune response after trauma: implications for the development of late onset sepsis. Shock. 2013;40(1): 21-7.
55. Morrison CA, Moran A, Patel S, del Vidaurre MPH, Carrick MM, Tweardy DJ. Increased apoptosis of peripheral blood neutrophils is associated with reduced incidence of infection in trauma patients with hemorrhagic shock. J Infection. 2013;66: 87-94.
56. Jimenez MF, Watson RW, Parodo J, Evans D, Foster D, Steinberg M, et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg. 1997;132(12): 1263-9 (Discussion 9-70).
57. Spruijt NE, Visser T, Leenen LPH. A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients. Crit Care. 2010;14: R150.
58. Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma. 2009;67: 221-7.
59. Pillay J, Kamp VM, Pennings M, Oudijk EJ, Leenen LP, Ulfman LH, Koenderman L. Acute-phase concentrations of soluble fibrinogen inhibit neutrophil adhesion under flow conditions in vitro through interactions with ICAM-1 and MAC-1 (CD11b/CD18). J Thromb Haemost. 2013;11(6): 1172-82.
60. Cruz-Topete D, Iwaki T, Ploplis VA, Castellino FJ. Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice. J Pathol. 2006;210: 325-33.
61. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the diseases other than hereditary angioedema. Pharmacol Rev. 2000;52: 91-112.
62. Kochilas L, Campbell B, Scalia R, Lefer AM. Beneficial effects of C1 esterase inhibitor in murine traumatic shock. Shock. 1997;8: 165-9.
63. Liu D, Lu F, Qin G, Fernandes SM, Li J, Davis AE 3rd. C1 inhibitor-mediated protection from sepsis. J Immunol. 2007;179: 3966-72.
64. Liu D, Zhang D, Scafidi J, Wu X, Cramer CC, Davis AE 3rd. C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood. 2005;105: 2350-5.
65. Dorresteijn MJ, Visser T, Cox LAE, Bouw MP, Pillay J, Koenderman AHL, Strengers PFW, Leenen LPH, van der Hoeven JG, Koenderman L, Pickkers P. C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia. Crit Care Med. 2010;38(11): 2139-45.
66. Heeres M, Visser T, van Wessem KJ, Koenderman AH, Strengers PF, Koenderman L, Leenen LP. The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture-the CAESAR study: study protocol for a randomized controlled trial. Trials. 2011;12: 223.